Sirnaomics Ltd.

HK$4.17As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2257Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 5Y CAGR (47.02%)
Div yield —
ROE —
Biotechnology
Beta (5Y) (0.07)
PE TTM —
TSR TTM (57.70%)
Mkt cap HK$464.8M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.00
19.87%
461.90%
Hold 11|4|4|2|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.05
0.05
0.06
30.76%
17.10%
7.53%
16.91%
Revenue$M
37.35
37.01
36.20
36.86
4.43%
(1.49%)
(4.00%)
0.53%
Peers (US$59.29M)
Cap (US$)
PE
81.72M
—
Capital
TTM
5Y
10Y
Leveragex
0.170
3.084
2.128
EBIT/Intx
1.014
0.707
0.567
Own earn%
(18.58)
(90.66)
(91.30)
Sh yield%
55.23
22.20
21.93
Owners
Insiders/Inst%
7.14
59.82
Short interest%
4.53
SBC / revenue%
4.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
18–24
$1 testx
—
Incr. ROIC%
16